Pharmaceutical Company Commends Advanced of the Year
Release time:
2020-08-14
Pharmaceutical Company Commends Annual Advanced
News 1# July 29 Afternoon, Peak Pharmaceutical Company Held 2017 Annual Summary Commendation Meeting to Summarize the Work of the Past Year, Commend the Outstanding Collectives and Individuals of Pharmaceutical Company 2017 , and Put forward the Work Ideas for the New Year.
2017 is an important year to deepen the reform in an all-round way. The pharmaceutical industry is in a period of policy adjustment and turbulence , . The frequent occurrence of national pharmaceutical policies, especially the continuous promotion of the new medical reform policy and the rapid landing of drug regulatory policies, have brought new opportunities and challenges to the pharmaceutical industry. In the face of the complex and changeable industrial situation and market environment, the pharmaceutical company closely revolves around the business objectives set at the beginning of the year, seizes the opportunity of industry integration and market expansion, carries out all kinds of work in a down-to-earth manner, and achieves good results. On behalf of the management team of the pharmaceutical company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, made a work report entitled "comply with new policies, meet new challenges, gather new forces to achieve new leaps". He made a report on the completion of economic indicators, scientific and technological innovation achievements, brand promotion of enterprises and products, enterprise expansion, completion and use of technological transformation projects, strengthening of internal management and refinement of marketing work, the party-mass work and other aspects reviewed the main work in 2017
2018 . He pointed out that 2018 is a very critical year for the pharmaceutical industry. The newly revised Drug Administration Law will be implemented, and the drug registration management measures, drug technology transfer management measures, drug marketing license holder system, GMP and GSP certification systems will be revised accordingly. With the continuous introduction of policies, the entire industry will undergo tremendous changes. Pharmaceutical companies will proceed from the actual situation of the company, fully tap their own advantages, take innovation and standardization as the main line, and steadily advance various tasks. At the meeting, he made arrangements for the key work of 2018 . Chairman of the Group Company and Chairman of the Pharmaceutical Company Jiang Xiaomeng, Chairman of the Trade Union of the Group Company Qin Xuping and leaders of the Pharmaceutical Company presented awards to the advanced collectives and individuals of the Pharmaceutical Company 2017
2017 respectively. Chairman Jiang Xiaomeng, on behalf of the group company, congratulated the commended advanced collectives and individuals, affirmed the efforts made by all employees of the pharmaceutical company in the past year, and put forward requirements for the work of pharmaceutical company 2018 . He asked pharmaceutical companies to increase talent training; speed up consistency evaluation and new drug research and development; establish the concept of marketing first responsibility, innovate marketing models; expand the scale of retail business; establish and improve internal assessment and incentive mechanisms to mobilize all levels The subjective initiative of personnel. At the
Ni Yingzhen)
More information
Company fully deploys 2019 work
On January 28, the group company held a business analysis meeting to review and summarize the work situation in 2018, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises made reports on the overall work situation in 2018, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2019. Xiang Chongping, deputy general manager of the group company, made a systematic review of the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the internal control, safety and environmental protection work in 2018. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2018 and made a comparative analysis of the main economic indicators of each industrial sector. In 2018, the operating indicators of the company's various industrial sectors have improved significantly year-on-year, and the group company has also created the best operating performance in history. All units have completed the formulation of the second round of "three-year business plan", which points out the direction for the next three years of business work; the group company has also completed the first draft of the new "five-year strategic development plan", which is being revised and enriched. In addition, the two main businesses have also made substantial progress in investment expansion and industrial integration around strategic objectives, and the operating costs of major enterprises have decreased to varying degrees; the optimization of organizational structure and post setting has achieved new results, and management efficiency and people
2020
07-22
Company fully deploys 2019 work
On January 28, the group company held a business analysis meeting to review and summarize the work situation in 2018, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises made reports on the overall work situation in 2018, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2019. Xiang Chongping, deputy general manager of the group company, made a systematic review of the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the internal control, safety and environmental protection work in 2018. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2018 and made a comparative analysis of the main economic indicators of each industrial sector. In 2018, the operating indicators of the company's various industrial sectors have improved significantly year-on-year, and the group company has also created the best operating performance in history. All units have completed the formulation of the second round of "three-year business plan", which points out the direction for the next three years of business work; the group company has also completed the first draft of the new "five-year strategic development plan", which is being revised and enriched. In addition, the two main businesses have also made substantial progress in investment expansion and industrial integration around strategic objectives, and the operating costs of major enterprises have decreased to varying degrees; the optimization of organizational structure and post setting has achieved new results, and management efficiency and people
2020
07-31
The truth about private equity investments you need to know.
China Securities Regulatory Commission Zhejiang Regulatory Bureau and China Securities Investor Protection Fund Co., Ltd. jointly launched the "those private equity fund investment truth you need to know" investment education products. With the outbreak of private equity investment, the proportion of individual investors has further increased, and there are more and more "rich myth" scams. But the things behind "private placement" may not be as simple as you think, and risk prevention knowledge needs to be known early.
2020
07-31
The truth about private equity investments you need to know.
China Securities Regulatory Commission Zhejiang Regulatory Bureau and China Securities Investor Protection Fund Co., Ltd. jointly launched the "those private equity fund investment truth you need to know" investment education products. With the outbreak of private equity investment, the proportion of individual investors has further increased, and there are more and more "rich myth" scams. But the things behind "private placement" may not be as simple as you think, and risk prevention knowledge needs to be known early.
2020
07-30
The truth about private equity investments you need to know.
China Securities Regulatory Commission Zhejiang Regulatory Bureau and China Securities Investor Protection Fund Co., Ltd. jointly launched the "those private equity fund investment truth you need to know" investment education products. With the outbreak of private equity investment, the proportion of individual investors has further increased, and there are more and more "rich myth" scams. But the things behind "private placement" may not be as simple as you think, and risk prevention knowledge needs to be known early.
2020
07-31
Chairman Jiang Xiaomeng Directs Work in Yunnan Peak
On December 16, Jiang Xiaomeng, Secretary of the Party committee and chairman of the group company, went to Yunnan Jianfeng cement company to investigate and guide the work. On the morning of the same day, accompanied by the Yunnan peak management team, Jiang Xiaomeng went deep into the front line and successively went to the central control room of the production and manufacturing department, the raw material clay yard, the lignite yard and other areas for field investigation and investigation to understand the problems existing in the production and operation process. Subsequently, a business analysis meeting was held to make a comparative analysis of the various business indicators of Yunnan Jianfeng from January to November this year, and put forward two requirements to the management team: further strengthen internal management and improve execution; strengthen the coordination of external relations, and improve The ability and level of enterprise resource acquisition. At the Yunnan Jianfeng middle-level cadre meeting held on the afternoon of the 16th, Jiang Xiaomeng first fully affirmed Yunnan Jianfeng's highest output and best benefits since it was put into production in 2018, and expressed his gratitude to all cadres and employees of Yunnan Jianfeng for their hard work. After that, Jiang Xiaomeng made a detailed analysis of the cement industry and the regional market environment in Yunnan, and combined with the current production and operation situation of Yunnan Jianfeng, put forward the focus of the next step: 1. should fully attach importance to and mobilize the initiative and responsibility of employees at all levels to improve the overall execution of the team; 2. raw material mines are an important factor restricting the future development of cement enterprises, which should be paid full attention to and formulate clear strategies and methods, set out a timetable to obtain future production resources as much as possible; 3. continuously advocate and promote technological innovation, keep pace with the times, continuously improve production management, equipment management, production technology level, and maintain the competitive advantage of the industry; 4. further strengthen production
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page